For the quarter ending 2025-09-30, HYEX had -$11,043 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income/(loss) | -395,394 | -331,739 |
| Depreciation and amortization | 634 | 695 |
| Discount expensed from note payable and convertible notes | 16,361 | 4,999 |
| Common stock issued for services | -349,981 | -34,169 |
| Warrants issued for services | 92,312 | 95,152 |
| Change in fair value on derivative liability | 120,891 | -53,468 |
| Accounts receivable | 27,284 | -7,024 |
| Deposit | 6,474 | - |
| Inventory | -140,357 | -254,337 |
| Note receivable | 291,890 | 100,000 |
| Offering costs | 0 | 0 |
| Right of use asset, net - current | 0 | 8,984 |
| Right of use asset, net - non-current | 14,725 | -180,811 |
| Accounts payable | 6,462 | 62,641 |
| Accrued liabilities | -61,300 | -24,613 |
| Accrued interest payable | 138 | 7,072 |
| Accrued interest payable - related party | 16,500 | 13,240 |
| Lease liability - current | 2,435 | 50,858 |
| Lease liability - long-term | -16,542 | 121,761 |
| Net cash provided by (used in) operating activities | -279,871 | 77,237 |
| Loan origination fees | - | 0 |
| Fixed asset purchase | 0 | 19,302 |
| Proceeds from issuance of common stock | - | 0 |
| Cash flows provided by (used in) investing activities | 0 | -19,302 |
| Proceeds from issuance of convertible debt | 0 | 0 |
| Payments for repayment of convertible debt | 63,467 | 83,437 |
| Proceeds from issuance of noted payable | 0 | 160,000 |
| Payments for repayment of notes payable | -48,051 | -8,498 |
| Proceeds from issuance of noted payable - related party | 400,000 | 0 |
| Payments for repayment of noted payable - related party | 19,655 | 37,524 |
| Net cash provided by (used in) financing activities | 268,829 | 30,539 |
| Increase (decrease) in cash | -11,043 | 88,475 |
| Cash and cash equivalents at beginning of period | 112,020 | - |
| Cash and cash equivalents at end of period | 189,452 | - |
HEALTHY EXTRACTS INC. (HYEX)
HEALTHY EXTRACTS INC. (HYEX)